Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BETAPACE AF

SOTALOL HYDROCHLORIDE

Standard Dose
60MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview BETAPACE AF is listed in Drugs@FDA under application 021151 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient SOTALOL HYDROCHLORIDE Form and strength TABLET;ORAL - 60MG Sponsor LEGACY PHARMA Submission history Latest submission status date: 2011-08-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview BETAPACE AF is listed in Drugs@FDA under application 021151 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient SOTALOL HYDROCHLORIDE Form and strength TABLET;ORAL - 60MG Sponsor LEGACY PHARMA Submission history Latest submission status date: 2011-08-17 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.